Advance Agrolife IPO
Advance Agrolife IPO Price Range is ₹95 - ₹100, with a minimum investment of ₹15,000 for 150 shares per lot.
Subscription Rate
56.85x
as on 03 Oct 2025, 07:00PM IST
Minimum Investment
₹15,000
/ 150 shares
IPO Status
Price Band
₹95 - ₹100
Bidding Dates
Sep 30, 2025 - Oct 3, 2025
Issue Size
₹192.86 Cr
Lot Size
150 shares
Min Investment
₹15,000
Listing Exchange
BSE
IPO Doc
Advance Agrolife IPO Application Timeline
IPO Subscription Status
as on 03 Oct 2025, 07:00PM IST
IPO subscribed over
🚀 56.85x
This IPO has been subscribed by 23.058x in the retail category and 27.305x in the QIB category.
Subscription Rate
| Total Subscription | 56.85x |
| Retail Individual Investors | 23.058x |
| Qualified Institutional Buyers | 27.305x |
| Non Institutional Investors | 175.3x |
Objectives of IPO
- The purpose of its Initial Public Offering (IPO) is to raise capital for the company's growth and general operational needs. The total size of the Issue aggregates up to ₹192.86 crore (only fresh issue).
- The company will utilize ₹135 crore of the Net Proceeds to meet its significant incremental working capital requirements. This allocation is based on projected operational needs stemming from factors such as anticipated sales growth, longer receivable cycles, and increased inventory and procurement requirements. The total working capital required is estimated to reach ₹215.03 crore in FY26 and increase further to ₹306.76 crore in FY27. It plans to deploy these funds over two years: ₹67.5 crore in FY26 and ₹67.5 crore in FY27. As context for its existing financial obligations, its total borrowings stood at ₹80.45 crore, resulting in a Debt-Equity Ratio of 0.80 times as of March 31, 2025.
- The balance of the IPO funds will be used for general corporate purposes. These funds are intended for strategic initiatives, brand building/marketing, capital expenditure, and ongoing general corporate exigencies, as approved by the management.
Financial Performance of Advance Agrolife
The company has shown steady growth over the last three fiscal years. Revenue increased at a CAGR of 12.4%, rising from ₹398 crores in FY23 to ₹502.9 crores in FY25, largely driven by higher domestic sales. Profit after tax (PAT) grew sharply between FY23 and FY24, jumping 66% to ₹24.7 crores due to improved operational efficiency and better supplier terms. In FY25, PAT edged up to ₹25.6 crores, while the PAT Margin slightly dipped to 5.1% because of higher operating costs, mainly from a 125% increase in depreciation linked to a new manufacturing facility.
The company expanded its asset base rapidly, with total assets rising at a 39.9% CAGR to ₹351.5 crores in FY25. This expansion was largely funded through debt, which surged at a 78.4% CAGR to ₹80.5 crores, raising the debt-to-equity ratio from 0.50 to 0.80 times. As a result, finance costs increased by 53.7%. EBITDA margins improved steadily from 6.3% in FY23 to 9.6% in FY25, reflecting better operational leverage despite rising costs.
Overall, the company has balanced growth with strategic investment in infrastructure, though rising debt and operating expenses may need close monitoring.
Strengths and Risks
Strengths
It operates an integrated production setup across three manufacturing facilities in Jaipur, Rajasthan, possessing a substantial annual installed capacity of 89,900 MTPA. This infrastructure allows production of both Technical and Formulation Grade products, granting high operational flexibility and opening new revenue streams.
The company has demonstrated consistent growth, achieving a revenue CAGR of 12.4% over the last two years, with FY25 revenue reaching ₹502.26 crore. Its profit after tax nearly doubled from ₹14.87 crore in FY23 to ₹25.64 crore in FY25.
It shows strong efficiency in converting capital into profits, indicated by a high Return on Net Worth (RoNW) of 29.11% and a Return on Capital Employed (ROCE) of 27.02% in FY25. These metrics demonstrate the company's efficient utilization of shareholder funds and total capital employed.
It maintains a strong and growing regulatory base, holding 410 generic registrations as of March 31, 2025, which includes 380 Formulation Grade and 30 Technical Grade products. This portfolio allows it to legally distribute products across 13 Indian states, enhancing market reach and stability.
The company benefits from long-standing B2B relationships with corporate customers, several of whom have been clients for periods ranging from 5 to over 9 years. This focus on quality and specific customer requirements ensures continuous revenue visibility and strengthens market presence through repeat orders.
Its Days Working Capital stood at 74 days in FY25, suggesting a faster conversion cycle compared to several large rivals. This is notably shorter than Insecticides India Limited (122 days) and PI Industries Limited (117 days).
Risks
The company faces a major risk from customer concentration, as its top 5 customers contributed ₹259.51 crore, representing 51.70% of total revenue in FY25. The loss of, or reduced revenue from, any of these key customers could materially and adversely affect its results.
The business is highly working capital intensive; net working capital rose to ₹100.34 crore in FY25. Projected working capital requirements are estimated to increase substantially to ₹306.76 crore by FY27, and failure to meet this large demand could hurt operations.
All manufacturing facilities are situated in Jaipur, Rajasthan, and a majority of its revenue (84% in FY25) is derived from key northern and central agricultural states. This geographic concentration exposes it to risks from adverse local factors, such as regional weather volatility or local regulatory changes.
Total borrowings have increased significantly, rising from ₹25.29 crore in FY23 to ₹80.45 crore in FY25. Consequently, the Debt-Equity Ratio has increased from 0.50 times to 0.80 times, indicating greater reliance on debt and higher interest obligations.
A significant amount of its trade receivables is concentrated in a single Group Company, HOK Agrichem Private Limited. The outstanding trade receivable balance owed by this entity reached ₹76.65 crore in FY25, up from ₹39.26 crore in FY24.
How to Apply for Advance Agrolife IPO on INDmoney
- Download the INDmoney app and complete your KYC.
- Go to INDstocks → IPO, or just search “IPO”.
- Tap on Advance Agrolife IPO from the list of live IPOs.
- View key details like price band, lot size, and dates.
- Tap Apply Now and choose your number of lots.
- Use INDpay UPI for instant mandate tracking.
- Your funds will be blocked until the share allotment is finalized.
Listed Competitors of Advance Agrolife
Company | Operating Revenue | EBITDA Margin | Profit | P/E Ratio | Return on Net Worth | Debt to Equity Ratio (x) | Days Working Capital |
Advance Agrolife | ₹502.3 Cr | 9.61% | ₹25.6 Cr | 25.07 | 29.11% | 0.8 | 74 |
₹951.0 Cr | 8.09% | ₹34.8 Cr | 34.6 | 9.24% | 0.29 | 73 | |
₹2,000.0 Cr | 11.41% | ₹142.0 Cr | 16.99 | 13.55% | 0.1 | 122 | |
₹1,409.7 Cr | 7.48% | ₹2.3 Cr | N/A | 0.37% | 0.41 | 48 | |
₹7,977.8 Cr | 31.63% | ₹1,660.2 Cr | 34.29 | 17.58% | 0.02 | 117 | |
₹4,319.9 Cr | 15.17% | ₹304.4 Cr | 30.33 | 12.85% | 0 | 113 |
Advance Agrolife Shareholding Pattern
| Promoters & Promoter Group | 99.84% | |
| Name | Role | Stakeholding |
| Om Prakash Choudhary | Promoter | 54.17% |
| Kedar Choudhary | Promoter | 36.05% |
| Geeta Choudhary | Promoter | 3.62% |
| Manisha Choudhary | Promoter | 3.28% |
| Kamla Devi Jat | Promoter Group | 2.72% |
| Others | Public | 0.16% |
About Advance Agrolife
The company operates primarily under a B2B (business-to-business) model, selling its products directly to corporate customers who then utilize their own distribution networks. This model creates reliance on major clients; for instance, its top 5 customers accounted for 51.70% of its FY25 revenue, totaling ₹259.51 crore. Its key domestic markets are concentrated in northern and central agricultural belt states, including Rajasthan, Maharashtra, Punjab, and Gujarat. To manage operations, the company utilizes a total annual installed capacity of 89,900 MTPA (Metric Tonnes Per Annum) spread across three manufacturing facilities in Jaipur, Rajasthan. It relies on a workforce of 269 permanent employees as of July 15, 2025.
In the competitive agrochemical sector, the company is positioning itself for sustained growth. While its FY25 revenue (₹502.26 crore) is smaller than established peers like PI Industries Limited (₹7,977.8 crore), its future strategy centers on vertical integration and market expansion. It plans to invest in backward integration by building a new facility dedicated to producing Technical Grade agrochemicals, aiming to secure its internal raw material supply. Furthermore, it proposes to acquire HOK Agrichem Private Limited, a related entity that previously handled B2C sales, in order to streamline business operations and enhance control. It also plans to invest resources in product registrations for export to developed markets, such as Europe, to expand its global footprint.
For more details, visit here: advanceagrolife.com
Know more about Advance Agrolife
Advance Agrolife IPO: GMP, Subscription, Strengths, Risks - Should You Apply?
Advance Agrolife IPO is open for subscription. Check GMP, subscription status, dates, business model, key risks, industry outlook, allotment details, and analyst view. In-depth research for informed investing.
Frequently Asked Questions of Advance Agrolife IPO
What is the size of the Advance Agrolife IPO?
What is the allotment date of the Advance Agrolife IPO?
What are the open and close dates of the Advance Agrolife IPO?
What is the lot size of Advance Agrolife IPO?
When will my Advance Agrolife IPO order be placed?
Can we invest in Advance Agrolife IPO?
What would be the listing gains on the Advance Agrolife IPO?
What is 'pre-apply' for Advance Agrolife IPO?
Who are the promoters of Advance Agrolife?
The promoters of Advance Agrolife are Om Prakash Choudhary, Kedar Choudhary, Geeta Choudhary, and Manisha Choudhary. This group collectively held 43,706,000 Equity Shares, representing 97.12% of the company's pre-IPO equity share capital.
Who are the competitors of Advance Agrolife?
It operates in a competitive market against both domestic and international players. Key listed industry peers used for quantitative comparison are PI Industries Limited, Insecticides India Limited, Sharda Cropchem Limited, Dharmaj Crop Guard Limited, and Heranba Industries Limited.
How does Advance Agrolife make money?
It generates revenue by manufacturing and distributing agrochemical products through a B2B model to corporate clients. In FY25, total revenue was ₹502.26 crore. Formulation Grade products dominate sales, accounting for 98.99%, or ₹497.20 crore, of revenue.